Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. TRASYLOL (aprotinine), antihémorragique
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

TRASYLOL (aprotinine), antihémorragique

Medicine - Posted on Mar 07 2022
Active substance (DCI)
  • aprotinine
history (2)
  • 1/19/22

    TRASYLOL (aprotinine)

    Réévaluation. Avis favorable au remboursement dans la réduction des saignements et des besoins transfusionnels chez les pati...
    CAV :
    54321
    icône flèche
  • 1/25/17

    TRASYLOL (aprotinin), antihaemorrhagic

    No proven clinical advantage over tranexamic acid for preventing bleeding and reducing transfusion needs during isolated cor...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • B02AB01 Inhibiteur de proteinases
Manufacturer
NORDIC PHARMA
Presentation

TRASYLOL 500 000 UIK/50 ml, solution injectable
50 ml de solution en flacon B/1 (CIP : 34009 557 222 1 2)

All our publications
    Blood coagulation and hemostasis disorders Cardiac surgery Drug therapy Myocardial ischemia Operative surgical procedures

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
eNq9mNty2jAQhu95Co/vbeOcCB1DpqVJy0wypSRMO73JCHsBUSE5K4lDn74ykNbp2JNGRLnEsnfX2l/f/ji5WC+YtwSUVPCOH4dN3wOeiozyaccf3V0F5/5Ft5HMyZKUbmuFzTA+8r2UESk7frEajoFwGX6/uf4I5nlAv9vwEjGeQ6qe3KcVZeFnImc3JC/u8ZKloJm3ADUTWcfPtdpe9RKp0FTRXQn8KXOSQhLtr5RX5/cn5etJVAT7j6haAl4TPq0MCtwqZqoRgaseUTAVuKmp99gqNpVDkEJjCgOiZgMUS5pBVpliQpgEqySTVXYLuGSgiiSVwaN5upBWwcmcrIfw0K8u+r1Z7am1CppB3DppH8Xts+O42Tq1SoWlrarugnmJKM8xuz9qnx+3TloR8EghkRsmWEByFIpyyiEgXNEZLAQimdIHDZa9GwhUhDnqGpW9p8JzlAfh4Vl1ZFTmjGzCucxtt4ogMcuABg/uXqR4gzs0wGJmz/6JzzVj0QurHu1x4qjiglY9obmqocrV0HYjeoIrWNd31A6Ear3XIgX5emF/CV49BAZ6zGhqizwDJQ1SjYb9euK9JSw+EAkjdEeLb5RnYiVfn0LlrjuqPt+CtDKoaVBcdOgsPj21PmQ/jMRqJtSlRpFDZPhE5SHY6fOJOBQ4RrXVoR41+2Zy3fookRIGNU4qsGST0emj8XN2Etydst1CZdBPl3e28vmqATe325+VoWnWKTfejt0uBoLRa23tL1f/DgJObLbGarjMlMrluyharVbhjMhAmsMD4QTffDiU5rW7PwFOTMHOJO0A66j08W5yvqyDtofxOdtwqBXeP7+33JU5FFrraPSH287o2r98fWD/9cHOyh48oYu7NFvPShQV3JVX0uNqo3ToiDCt5VdoGPFlMqE132VqpZlEu29C3UYSFd+Duo3fLXwcRg==
7B3pdap2m00UKPWc